Usana Health Sciences Inc

Research Usana Health Sciences Inc (USNA) on Bullrun: valuation model: 47.0% overvalued, market cap USD 387.91M, P/E 44.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerUSNA
ExchangeNYSE
CountryUnited States
SectorConsumer Defensive
IndustryPackaged Foods
CurrencyUSD
Valuation signal47.0% overvalued
Market capUSD 387.91M
P/E44.2
Financial periodFY2026
RevenueUSD 925.26M
Revenue growth8.3%
Net incomeUSD 10.76M
Free cash flowUSD 8.53M
Gross margin78.3%

Valuation Snapshot

Bullrun's latest valuation model marks Usana Health Sciences Inc as 47.0% overvalued; latest market cap is USD 387.91M; P/E is 44.2.

About Usana Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age;

Frequently asked questions

Is Usana Health Sciences Inc overvalued or undervalued?

Bullrun's valuation model currently marks Usana Health Sciences Inc as 47.0% overvalued.

What is Usana Health Sciences Inc's market cap?

Usana Health Sciences Inc's market capitalization is USD 387.91M.

What is Usana Health Sciences Inc's P/E ratio?

Usana Health Sciences Inc's price-to-earnings (P/E) ratio is 44.2.